Wordt geladen...
Bevacizumab for acute neurologic deterioration in patients with glioblastoma
AIM: Glioblastoma causes neurologic dysfunction owing to the tumor's location and peritumoral edema. Bevacizumab improves symptoms and steroid dependence, and may rescue glioblastoma patients hospitalized for acute neurologic dysfunction, allowing them to return home for outpatient treatment. M...
Bewaard in:
| Gepubliceerd in: | CNS Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6136096/ https://ncbi.nlm.nih.gov/pubmed/25054664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.13.40 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|